Abstract
Proteins are susceptible to numerous non-enzymatic post-translational modifications which occur both during normal aging and in neurodegenerative states. For instance, formation of abnormal L-isoaspartyl residues arising from both the deamidation of L-asparaginyl residues and the isomerization of L-aspartyl residues is a frequent chemical modification that affects proteins. The formation of L- isoaspartyl residues in proteins alters their three-dimensional structure leading usually to a loss of function. Notably, accumulation of isomerized proteins could contribute to metabolic dysfunctions in neuronal cells during aging reducing cognitive functions in elderly patients and would eventually promote the development of neurodegenerative diseases. The protein L-isoaspartyl (D-aspartyl) methyltransferase (PIMT) is an enzyme that recognizes and repairs the abnormal L-isoaspartyl residues in proteins. Its expression appears to decline during aging which could partially explain the build up of damaged proteins in old age. In this review, we summarize recent findings, based mostly on proteomic data, regarding the formation and accumulation of proteins bearing atypical L-isoaspartyl residues as well as PIMT functions during normal aging and in some neurodegenerative diseases. The emphasis is on possible molecular mechanisms controlling PIMT expression and the ability of PIMT to repair isomerized substrates during aging. Investigation of processes regulating age-related accumulation of isomerized proteins is a promising avenue to a better understanding of aging at the protein level.
Keywords: Aging, Damaged proteins, L-isoaspartyl residues, PIMT, deamidation, L-asparaginyl residues, L-aspartyl residues, neurodegenerative diseases, lipid peroxidation, oxidation, glycation, isomerization, racemization, A-crystallin, protein kinase A (PKA), fibronectin, v3-integrin binding, monomeric enzyme, alanine, proteomic analysis, immunobloting, brain cytosol, hemodialysis fluid, cerebrospinal fluid, amniotic fluid, methylation, cortex, hippocampus, hypothalamus, striatum, immunochemical analysis, thalamus, amygdala, methamphetamine, epilepsy, cerebellum, schizophrenia, Huntington's disease, methyltransferase, synaptosomes, synuclein, Parkinson's disease, synuclein fibrils, Lewy bodies, immunohistochemistry, immunoreactivity, lymphocytes, methyl acceptor proteins, tubulin, insulin-like growth factor-I (IGF-I), estradiol, valproic acid, lysosomes, proteasomal activity, Alzheimer's disease, dementia, intraneuronal neurofibrillary tangles, amyloid (A) peptide, autopsy, cortical neuritic plaques, amyloid plaques
Current Aging Science
Title: Damaged Proteins Bearing L-Isoaspartyl Residues and Aging: A Dynamic Equilibrium Between Generation of Isomerized Forms and Repair by PIMT
Volume: 4 Issue: 1
Author(s): Richard R. Desrosiers and Irvens Fanelus
Affiliation:
Keywords: Aging, Damaged proteins, L-isoaspartyl residues, PIMT, deamidation, L-asparaginyl residues, L-aspartyl residues, neurodegenerative diseases, lipid peroxidation, oxidation, glycation, isomerization, racemization, A-crystallin, protein kinase A (PKA), fibronectin, v3-integrin binding, monomeric enzyme, alanine, proteomic analysis, immunobloting, brain cytosol, hemodialysis fluid, cerebrospinal fluid, amniotic fluid, methylation, cortex, hippocampus, hypothalamus, striatum, immunochemical analysis, thalamus, amygdala, methamphetamine, epilepsy, cerebellum, schizophrenia, Huntington's disease, methyltransferase, synaptosomes, synuclein, Parkinson's disease, synuclein fibrils, Lewy bodies, immunohistochemistry, immunoreactivity, lymphocytes, methyl acceptor proteins, tubulin, insulin-like growth factor-I (IGF-I), estradiol, valproic acid, lysosomes, proteasomal activity, Alzheimer's disease, dementia, intraneuronal neurofibrillary tangles, amyloid (A) peptide, autopsy, cortical neuritic plaques, amyloid plaques
Abstract: Proteins are susceptible to numerous non-enzymatic post-translational modifications which occur both during normal aging and in neurodegenerative states. For instance, formation of abnormal L-isoaspartyl residues arising from both the deamidation of L-asparaginyl residues and the isomerization of L-aspartyl residues is a frequent chemical modification that affects proteins. The formation of L- isoaspartyl residues in proteins alters their three-dimensional structure leading usually to a loss of function. Notably, accumulation of isomerized proteins could contribute to metabolic dysfunctions in neuronal cells during aging reducing cognitive functions in elderly patients and would eventually promote the development of neurodegenerative diseases. The protein L-isoaspartyl (D-aspartyl) methyltransferase (PIMT) is an enzyme that recognizes and repairs the abnormal L-isoaspartyl residues in proteins. Its expression appears to decline during aging which could partially explain the build up of damaged proteins in old age. In this review, we summarize recent findings, based mostly on proteomic data, regarding the formation and accumulation of proteins bearing atypical L-isoaspartyl residues as well as PIMT functions during normal aging and in some neurodegenerative diseases. The emphasis is on possible molecular mechanisms controlling PIMT expression and the ability of PIMT to repair isomerized substrates during aging. Investigation of processes regulating age-related accumulation of isomerized proteins is a promising avenue to a better understanding of aging at the protein level.
Export Options
About this article
Cite this article as:
R. Desrosiers Richard and Fanelus Irvens, Damaged Proteins Bearing L-Isoaspartyl Residues and Aging: A Dynamic Equilibrium Between Generation of Isomerized Forms and Repair by PIMT, Current Aging Science 2011; 4 (1) . https://dx.doi.org/10.2174/1874609811104010008
DOI https://dx.doi.org/10.2174/1874609811104010008 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Transglutaminase Inhibition as a Possible Therapeutical Approach to Protect Cells from Death in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Genes Underlying Monogenic and Multigenic Epilepsies in Mice
Current Genomics Structural Bioinformatics in Broad-Spectrum Racemases: A New Path in Antimicrobial Research
Current Organic Chemistry Cancer Diagnosis and Treatment Guidance: Role of MRI and MRI Probes in the Era of Molecular Imaging
Current Pharmaceutical Biotechnology The DREAM of Pain Relief
Current Rheumatology Reviews Editorial [Hot Topic: Glutamate Receptors and Related Processes as Drug Targets (Guest Editor: Michel Baudry)]
Current Drug Targets Recent Advances in Antiepileptic Herbal Medicine
Current Neuropharmacology Omega-3 Fatty Acids and their Role in Central Nervous System - A Review
Current Medicinal Chemistry Editorial (Thematic Issue: Epilepsy and Its Therapy: Present and Future)
Current Medicinal Chemistry FTY720 (Fingolimod) Ameliorates Brain Injury through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment
Current Medicinal Chemistry Trypanosomatid Parasites Causing Neglected Diseases
Current Medicinal Chemistry Identifying Endogenous Neural Stem Cells in the Adult Brain In Vitro and In Vivo: Novel Approaches
Current Pharmaceutical Design Nose-to-Brain Drug Delivery by Nanoparticles in the Treatment of Neurological Disorders
Current Medicinal Chemistry <i>Rhanterium suaveolens</i>, Vitamin E and C Pretreatment Prevents Valproic Acid Induced Renal Oxidant Damage
The Natural Products Journal Xenosensors CAR and PXR at Work: Impact on Statin Metabolism
Current Drug Metabolism Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders
Current Topics in Medicinal Chemistry Flavonoids and other Non-alkaloidal Constituents of Genus Erythrina: Phytochemical Review
Combinatorial Chemistry & High Throughput Screening Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis
Current Drug Safety Role of NUCB2/nesfatin-1 as a Possible Biomarker
Current Pharmaceutical Design O-Arylation of Iodophenols with 2-Fluorobenzaldehyde Under Microwave Conditions
Letters in Drug Design & Discovery